Pre-strained stent elements
The self-expanding endoprosthesis addresses the challenge of maintaining graft diameter by using a stent element with a higher yield strength to resist plastic deformation, ensuring effective expansion and reduced delivery profile.
Patent Information
- Application Number
- JP2023132652
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-01-31
- Filing Date
- 2023-08-16
- Publication Date
- 2024-11-07
- Estimated Expiration
- 2038-01-29
AI Technical Summary
Existing medical stents and stent-grafts face challenges in effectively expanding and maintaining the diameter of graft components within body lumens, particularly in areas constricted by lesions or tumors, without causing plastic deformation or failure.
A self-expanding endoprosthesis with a stent element and graft component, where the stent element exerts a radial expansion force on the graft, which has a higher yield strength, allowing it to maintain the expanded diameter even under greater forces, and is configured to collapse for delivery.
The endoprosthesis effectively expands and maintains the graft diameter, reducing the risk of plastic deformation and failure, while minimizing delivery profile for easier access to treatment sites.
Smart Images

Figure 0007579400000001 
Figure 0007579400000002 
Figure 0007579400000003
Abstract
Description
[Background technology]
[0001] background Medical stents, grafts and stent-grafts have a variety of applications including expanding a body lumen, such as a blood vessel, that has a constricted diameter. The blood vessel may be diseased, constricted or otherwise damaged, for example, due to the effects of lesions called atheromas or the development of cancerous tumors. Atheromas refer to lesions in arteries that include plaque buildup that may impede blood flow within the vessel. Over time, the plaque increases in size and thickness and may eventually cause clinically significant arterial stenosis or even complete occlusion. When expanded against a constricted diameter body lumen, the medical stent provides a tubular support structure inside the lumen. Further non-limiting examples of applications of stents, grafts and / or stent-grafts include endovascular repair of aneurysms, abnormal widening or ballooning of a portion of a body lumen that may be associated with a weakness in the wall of the lumen. Summary of the Invention
[0002] overview Various aspects of the present disclosure are directed to a self-expanding endoprosthesis having a contracted configuration and a deployed configuration. The self-expanding endoprosthesis can include a self-expanding stent element having an enlarged diameter and a graft component attached to at least a portion of the self-expanding stent element and having an enlarged diameter smaller than the enlarged diameter of the self-expanding stent in the deployed configuration. Furthermore, in the deployed configuration, the self-expanding stent element can exert a radially expansive force on the graft component. The graft component can have a yield strength greater than the radially expansive force and is configured to radially maintain the self-expanding stent element at the enlarged diameter of the graft component upon application of a second radially expansive force greater than the radially expansive force of the self-expanding stent element.
[0003] Aspects of the present disclosure are also directed to a self-expanding endoprosthesis having a self-expanding stent element having an as-manufactured diameter of 7 mm to 32 mm and a graft component having an expanded diameter of 5 mm to 27 mm. The self-expanding stent element can include a self-deployed diameter that is at least 2% to 25% greater than the expanded diameter of the graft component. Additionally, the expandable stent element can be at least partially attached to the graft component. Furthermore, once the self-expanding endoprosthesis is fully deployed, the self-expanding stent element can continue to exert an outward force against the graft component without expanding beyond the expanded diameter of the graft component.
[0004] Various aspects of the present disclosure are also directed to a self-expanding endoprosthesis including a self-expanding stent element having a neutral diameter of 22 mm to 58 mm and a graft component having an expanded diameter of 20 mm to 53 mm and attached to the self-expanding stent element. The self-expanding stent element and the graft component can be configured to be contracted from a fully deployed configuration to a delivery configuration for introduction into a patient. Furthermore, the self-expanding stent element's self-deployed diameter can be at least 2% to 25% greater than the expanded diameter of the graft component, and the graft component is configured to maintain the self-expanding stent element at the expanded diameter of the graft component.
[0005] Aspects of the present disclosure are further directed to a self-expanding endoprosthesis having a contracted configuration and a deployed configuration. The self-expanding endoprosthesis can include a self-expanding stent element having an expanded diameter and a diametric constraint coupled to at least a portion of the self-expanding stent element. The diametric constraint can be configured to constrain a portion of the self-expanding stent to an expanded diameter that is smaller than the expanded diameter of the self-expanding stent element in the deployed configuration. In the deployed configuration, the self-expanding stent element can exert a radial expansion force on the graft component. Additionally, the graft component includes a yield strength greater than the radial expansion force and is configured to radially maintain the self-expanding stent element at the expanded diameter of the graft component upon application of a second radial expansion force greater than the radial expansion of the self-expanding stent element.
[0006] Various aspects of the present disclosure are also directed to a self-expanding endoprosthesis having a collapsed configuration and a deployed configuration. The self-expanding endoprosthesis can include a self-expanding stent element having an as-manufactured diameter and an expanded diameter, and a graft component attached to the self-expanding stent element and having an expanded diameter smaller than the expanded diameter of the self-expanding stent element in the deployed configuration. Furthermore, the self-expanding stent can be configured to respond to being collapsed to the collapsed configuration and to exhibit a plastic strain at the deployed diameter.
[0007] Various aspects of the present disclosure are also directed to methods of manufacturing a self-expanding endoprosthesis having a collapsed configuration and a deployed configuration. The method can include reducing a self-expanding stent element from an as-manufactured diameter to an expanded diameter of a graft component. The method can also include coupling the self-expanding stent element to a graft component at the expanded diameter of the graft component. Additionally, the method can include inducing a plastic strain in the self-expanding stent element by reducing the self-expanding endoprosthesis to the collapsed configuration.
[0008] Various aspects of the present disclosure are also directed to a method of treating a target location in a patient's vessel with a self-expanding endoprosthesis having a collapsed configuration and an expanded configuration. The method can include positioning the self-expanding endoprosthesis at the target location. The self-expanding endoprosthesis can include a self-expanding stent element having an as-manufactured diameter and an expanded diameter, and a graft component attached to the self-expanding stent element and having an expanded diameter smaller than the expanded diameter of the self-expanding stent element in the deployed configuration. The graft component can be coupled to the self-expanding stent element to collapse the self-expanding stent element from the as-manufactured diameter to the expanded diameter of the graft component. The self-expanding stent can be configured to exhibit a plastic strain in response to collapsing to the collapsed configuration and to exhibit a plastic strain at the deployed diameter. The method can also include expanding the self-expanding endoprosthesis from the collapsed configuration to the deployed configuration.
[0009] According to one example ("Example 1"), a self-expanding endoprosthesis having a contracted configuration and an expanded configuration includes: a self-expanding stent element having an expanded diameter; and a graft component attached to at least a portion of the self-expanding stent element and having an expanded diameter smaller than the expanded diameter of the self-expanding stent element in the expanded configuration, where in the expanded configuration, the self-expanding stent element exerts a radial expansion force on the graft component, the graft component having a yield strength greater than the radial expansion force, and configured to radially maintain the self-expanding stent element at the expanded diameter of the graft component upon application of a second radial expansion force greater than the radial expansion force of the self-expanding stent element.
[0010] According to yet another example to Example 1 ("Example 2"), the graft component is configured to resist plastic deformation upon application of a second radial expansion force.
[0011] According to yet another example ("Example 3") to any one of Examples 1-2, the expanded diameter of the self-expanding stent element is 2% to 25% greater than the expanded diameter of the graft component.
[0012] According to yet another example ("Example 4") to any one of Examples 1-3, the graft component is a continuous structure attached to a self-expanding stent element to form the flow lumen of the self-expanding endoprosthesis.
[0013] According to yet another example ("Example 5") to any one of Examples 1-4, the self-expanding stent element includes a plurality of undulations formed by struts connecting the apexes.
[0014] According to yet another variation to Example 5 ("Example 6"), the apex includes an arch ventral surface and an arch posterior surface, and the graft component is configured to reduce tensile stress at the arch ventral surface of the apex.
[0015] According to yet another variation to Example 5 ("Example 7"), the apex includes an arch ventral surface and an arch posterior surface, and the graft component is configured to maintain compression on the apex arch ventral surface.
[0016] According to yet another variation to Example 7 ("Example 8"), the self-expanding stent element and graft component are contracted to a contracted configuration and the apex arch ventral surfaces remain compressed after expansion to the deployed configuration.
[0017] According to yet another alternative to any one of Examples 1-8 ("Example 9"), the self-expanding stent elements are heat set to their as-manufactured diameter.
[0018] According to yet another variation to Example 9 ("Example 10"), the as-manufactured diameter of the self-expanding stent element is 15% to 20% larger than the expanded diameter of the graft component.
[0019] According to yet another example ("Example 11") to any one of Examples 1-10, the as-manufactured diameter of the self-expanding stent element is about 1 mm to 3 mm larger than the expanded diameter of the graft component.
[0020] According to yet another example ("Example 12") to any one of Examples 1-11, the self-expanding stent element and graft component are configured to compress to a reduced diameter of between 4 French and 26 French.
[0021] According to yet another alternative to Example 12 ("Example 13"), the expanded diameter of the graft component is between 2 mm and 53 mm.
[0022] According to yet another example ("Example 14") to any one of Examples 1-3, the self-expanding stent element has an as-manufactured diameter of 7 mm to 32 mm, and the graft component has an expanded diameter of 5 mm to 27 mm.
[0023] According to yet another example to Example 14 ("Example 15"), the graft component is configured to resist a radial expansion force greater than the outward force from the self-expanding stent element without expanding beyond an expanded diameter of the graft component, and the radial expansion force is between 3 atmospheres and 6 atmospheres.
[0024] According to one example ("Example 16"), a self-expanding endoprosthesis includes a self-expanding stent element having an as-manufactured diameter of 7 mm to 32 mm, a graft component having an expanded diameter of 5 mm to 27 mm, where the self-expanding stent element has a self-deployed diameter at least 2% to 25% greater than the expanded diameter of the graft component, and the self-expanding stent element is at least partially attached to the graft component, where when the self-expanding endoprosthesis is fully deployed, the self-expanding stent element continues to exert an outward force against the graft component without expanding beyond the expanded diameter of the graft component.
[0025] According to yet another example to Example 16 ("Example 17"), the graft component is configured to resist a radial expansion force greater than the outward force from the self-expanding stent element without expanding beyond an expanded diameter of the graft component, the radial expansion force being between 3 atmospheres and 6 atmospheres.
[0026] According to yet another example ("Example 18") to any one of Examples 16-17, the self-expanding stent element includes a plurality of undulations formed by struts, the apex includes an arch ventral surface and an arch posterior surface, and the graft component is configured to maintain compression of the arch ventral surface of the apex.
[0027] According to yet another example to Example 18 ("Example 19"), the self-expanding stent element is reduced from its as-manufactured diameter to its self-deployed diameter prior to attachment of the graft component thereto, placing the apical arch ventral surface in compression upon attachment.
[0028] According to one example ("Example 20"), a self-expanding endoprosthesis includes a self-expanding stent element having a neutral diameter of 22 mm to 58 mm, a graft component having an expanded diameter of 20 mm to 53 mm and attached to the self-expanding stent element, where the self-expanding stent element and the graft component are configured to contract from a fully deployed configuration to a delivery configuration for introduction into a patient, where the self-expanding stent element has a self-expanded diameter at least 2% to 25% greater than the expanded diameter of the graft component, and where the graft component is configured to maintain the self-expanding stent element at the expanded diameter of the graft component.
[0029] According to yet another example to Example 20 ("Example 21"), the self-expanding stent element is oversized relative to the graft component in a fully deployed configuration, thereby imposing an outward force on the graft component.
[0030] According to yet another example to Example 20 ("Example 22"), the graft component is configured to resist a radial expansion force greater than the outward force from the self-expanding stent element without expanding beyond an expanded diameter of the graft component, the radial expansion force being between 3 atmospheres and 6 atmospheres.
[0031] According to one example ("Example 23"), a self-expanding endoprosthesis having a contracted configuration and an expanded configuration includes a self-expanding stent element having an expanded diameter, and a diametrical constraint coupled to at least a portion of the self-expanding stent element, the diametrical constraint configured to constrain a portion of the self-expanding stent to an expanded diameter smaller than the expanded diameter of the self-expanding stent element in the expanded configuration, where in the expanded configuration, the self-expanding stent element exerts a radial expansion force on a graft component, the graft component having a yield strength greater than the radial expansion force and configured to radially maintain the self-expanding stent element at the expanded diameter of the graft component upon imposition of a second radial expansion force greater than the radial expansion force of the self-expanding stent element.
[0032] According to yet another variation to Example 23 ("Example 24"), the diametric constraint is a filament that is woven through a portion of the self-expanding stent element.
[0033] According to one example ("Example 25"), a self-expanding endoprosthesis having a contracted configuration and an expanded configuration includes a self-expanding stent element having an as-manufactured diameter and an expanded diameter, and a graft component attached to the self-expanding stent element and having an expanded diameter smaller than the expanded diameter of the self-expanding stent element in the expanded configuration, where the self-expanding stent is configured to exhibit plastic strain at the expanded diameter in response to being contracted to the contracted configuration.
[0034] According to one example ("Example 26"), a method of manufacturing a self-expanding endoprosthesis having a contracted configuration and an expanded configuration, the method includes reducing a self-expanding stent element from an as-manufactured diameter to an expanded diameter of a graft component, coupling the self-expanding stent element to the graft component at the expanded diameter of the graft component, and inducing plastic strain in the self-expanding stent element by contracting the self-expanding endoprosthesis to the contracted configuration.
[0035] According to one example ("Example 27"), a method of treating a target location within a vessel of a patient with a self-expanding endoprosthesis having a collapsed configuration and an expanded configuration, the method includes positioning the self-expanding endoprosthesis at the target location, where the self-expanding endoprosthesis includes a self-expanding stent element having an as-manufactured diameter and an expanded diameter, and a graft component attached to the self-expanding stent element and having an expanded diameter smaller than the expanded diameter of the self-expanding stent element in the expanded configuration, the graft component being coupled to the self-expanding stent element to expand the self-expanding stent element. From manufacturing diameter Graft Components Expansion of the self-expanding stent element is configured to exhibit a plastic strain in response to being contracted to the contracted configuration and at the deployed diameter; and expanding the self-expanding endoprosthesis from the contracted configuration to the deployed configuration.
[0036] While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive. [Brief description of the drawings]
[0037] BRIEF DESCRIPTION OF THE DRAWINGS [Figure 1A] FIG. 1A illustrates an example of a self-expanding stent element at an as-manufactured diameter, consistent with various aspects of the present disclosure. [Figure 1B] FIG. 1B illustrates a self-expanding endoprosthesis including a graft component attached to a self-expanding stent element as shown in FIG. 1A, consistent with various aspects of the present disclosure. [Figure 1C] FIG. 1C illustrates a self-expanding endoprosthesis, as shown in FIG. 1B, at its reduced diameter, consistent with various embodiments of the present disclosure. [Figure 2A] FIG. 2A illustrates another example of a self-expanding stent at an expanded diameter, consistent with various aspects of the present disclosure. [Figure 2B]FIG. 2B illustrates a first configuration of the diametrical constraint and self-expanding stent elements as shown in FIG. 2A, consistent with various aspects of the present disclosure. [Figure 2C] FIG. 2C illustrates a second configuration of the diametrical constraint and self-expanding stent elements as shown in FIG. 2A, consistent with various aspects of the present disclosure. [Diagram 3] FIG. 3 illustrates an exemplary self-expanding endoprosthesis in a collapsed configuration, consistent with various aspects of the present disclosure. [Figure 4] FIG. 4 illustrates another exemplary self-expanding endoprosthesis, consistent with various aspects of the present disclosure. [Diagram 5] FIG. 5 illustrates an example of a self-expanding endoprosthesis including a graft component and a self-expanding stent element with a portion of the self-expanding stent element detached from the graft component, consistent with various aspects of the present disclosure. [Figure 6] FIG. 6 illustrates a graph consistent with various aspects of the present disclosure. [Figure 7] FIG. 7 illustrates a self-expanding endoprosthesis consistent with various embodiments of the present disclosure. [Figure 8] FIG. 8 illustrates another self-expanding endoprosthesis consistent with various embodiments of the present disclosure. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0038] While the disclosed subject matter is susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the disclosure to the specific embodiments described. On the contrary, the disclosure is intended to cover all modifications, equivalents, and alternatives falling within the scope of the disclosed subject matter as characterized by the appended claims.
[0039] When terms are used herein in relation to ranges of measurements (e.g., those disclosed immediately above), "about" and "approximately" may be used interchangeably and refer to measurements that include the stated measurement and also include measurements that are reasonably close to the stated measurement, but may differ by reasonably small amounts as understood and readily ascertained by one of ordinary skill in the art due to measurement errors, variations in measurements and / or calibration of manufacturing equipment, human error in reading and / or setting measurements, adjustments to optimize performance and / or construction parameters to account for differences in measurements relative to other components, specific implementation scenarios, imprecise adjustments by humans or machines and / or manipulation of objects, and the like.
[0040] Similarly, although an example method may be represented by one or more drawings (e.g., flow diagrams, communication flows, etc.), the drawings should not be construed as implying a requirement or a particular order of the various steps disclosed herein. However, certain embodiments may call for certain steps and / or a particular order of certain steps (e.g., performance of some steps may depend on the results of previous steps), as may be explicitly described herein and / or as may be understood from the nature of the steps themselves. Furthermore, a "set," "subset," or "group" of items (e.g., inputs, algorithms, data values, etc.) can include one or more items, and similarly, a subset or subgroup of items can include one or more items. "Plurality" means more than one.
[0041] Detailed Description Various aspects of the present disclosure are directed to a medical device (or self-expanding endoprosthesis) that includes a self-expanding stent element attached to a graft component. In certain instances, the stent graft can be delivered to a target location via a transcatheter approach. Thus, the stent graft can be reduced to a delivery configuration. Minimizing the delivery profile (e.g., the diameter of the stent graft in the delivery configuration) can facilitate access to the treatment site and reduce the risk of access site complications.
[0042] FIG. 1A illustrates an example of a self-expanding stent 100 at an as-manufactured diameter 102 consistent with various aspects of the present disclosure. The self-expanding stent element 100 is illustrated in FIG. 1A at the as-manufactured diameter 102 of the self-expanding stent element 100. In certain cases, the self-expanding stent element 100 can be heat set at the as-manufactured diameter 102 of the self-expanding stent element 100. Additionally, the self-expanding stent 100 can be a multi-apex wire-wound stent (e.g., as described in further detail with reference to FIG. 4). The self-expanding stent 100 can form a portion of a self-expanding endoprosthesis 104 as shown in FIG. 1B.
[0043] FIG. 1B illustrates a self-expanding endoprosthesis 104 that includes a graft component 106 attached to at least a portion of a self-expanding stent element 100. In certain cases, the graft component 106 is a continuous structure attached to the self-expanding stent element 100 and forms a flow lumen of the self-expanding endoprosthesis 104. As shown in FIG. 1B, the self-expanding endoprosthesis 104 is shown in a deployed configuration. The graft component 106 is positioned at an expanded diameter 108 of the graft component 106 in the deployed configuration of the self-expanding endoprosthesis 104. In certain cases, the expanded diameter 108 of the graft component 106 in the deployed configuration of the self-expanding endoprosthesis 104 can be between about 5 mm and 27 mm.
[0044] The as-manufactured diameter 102 of the self-expanding stent element 100 may be approximately 1 mm to 5 mm larger (e.g., 2 mm to 5 mm, 5 mm to 13 mm, 35 mm to 53 mm, or any dimension therebetween) than the expanded diameter 108 of the graft component 106 in the deployed configuration of the self-expanding endoprosthesis 104. In other cases, the as-manufactured diameter 102 of the self-expanding stent element 100 may be 2% to 20% larger than the expanded diameter 108 of the graft component 106 in the deployed configuration of the self-expanding endoprosthesis 104. The expanded diameter of the graft component 106 may be smaller than the expanded diameter of the self-expanding stent element 100. For example, the expanded diameter 108 of the graft component 106 may be 5 mm to 27 mm, and in other cases, the expanded diameter 108 of the graft component 106 may be 20 mm to 53 mm. In either case, the as-manufactured diameter 102 of the self-expanding stent element 100 is between 2% and 20% larger than the expanded diameter 108 of the graft component 106 .
[0045] In certain cases, when the self-expanding endoprosthesis 104 is in a deployed configuration, the self-expanding stent element 100 can be configured to exert a radial expansion force along the graft component 106. The graft component 106 can have a yield strength greater than the radial expansion force exerted by the self-expanding stent element 100. Additionally, the graft component 106 can be configured to radially maintain the self-expanding stent element 100 at the expanded diameter of the graft component 106 upon application of a second radial expansion force greater than the radial expansion force of the self-expanding stent element 100.
[0046] The second radial expansion force may be sufficient to expand the graft component 106 to the enlarged diameter without plastically deforming to a diameter greater than the enlarged diameter. The second radial expansion force may depend on the diameter of the self-expanding stent element 100 and / or the graft component 106. For example, a larger diameter graft component 106 may be less resistant to an expansion force than a smaller diameter graft component 106. In certain cases, the second radial expansion force is between 3 atmospheres (atm) and 6 atmospheres (atm). In certain cases, the graft component 106 may have a yield strength such that the second radial expansion force may be applied for 10 seconds, 20 seconds, or 30 seconds without the diameter of the graft component 106 expanding by more than 0.5 mm. In certain cases, the graft component 106 does not expand by more than 0.1 mm, 0.2 mm, or 0.3 mm, or 0.4 mm in response to a force applied thereto.
[0047] In certain cases, graft component 106 is configured to resist plastic deformation (and / or resist fracture and breakage) upon application of a second radial expansion force. Graft component 106 can be configured, for example, to maintain self-expanding endoprosthesis 104 at its expanded diameter 108 in response to the second radial expansion force. Graft component 106 reduces the expansion of self-expanding endoprosthesis 104, as opposed to allowing self-expanding endoprosthesis 104 to expand in response to the second radial expansion force.
[0048] Additionally, the as-manufactured diameter 102 of the self-expanding stent element 100 can be between 7 mm and 32 mm, and the expanded diameter 108 of the graft component 106 can be between 5 mm and 27 mm. In certain cases, the as-manufactured diameter 102 of the self-expanding stent element 100 can be between 22 mm and 58 mm, and the expanded diameter 108 of the graft component 106 can be between 20 mm and 53 mm (1 mm to 5 mm smaller than the as-manufactured diameter 102 of the self-expanding stent element 100). In certain cases, the expanded diameter 110 of the self-expanding stent element 100 is between 2% and 25% larger than the expanded diameter 108 of the graft component 106 after plastic deformation from the as-manufactured diameter 102.
[0049] FIG. 1C illustrates the self-expanding endoprosthesis 104 at its reduced diameter 112, as shown in FIG. 1A, consistent with various aspects of the present disclosure. At reduced diameter 112, the self-expanding endoprosthesis 104 can be configured in a delivery configuration for insertion into a patient. Furthermore, the self-expanding stent element 100 and graft component 106 are configured to reduce to a reduced diameter 112 of about 4 French to about 24 French. Depending on the diameter of the self-expanding stent element 100 and graft component 106, other reduced diameters are possible. In certain cases, the self-expanding endoprosthesis 104 is reduced to a diameter such that the self-expanding stent element 100 induces a plastic strain.
[0050] In certain cases, the self-expanding endoprosthesis 104 can be reduced in size beyond the onset of plastic strain in the self-expanding stent element 100, for example, the self-expanding endoprosthesis 104 can be reduced 0.5 mm, 1 mm, 1.5 mm, 2 mm, 2.5 mm, 3 mm, 3.5 mm, 4 mm, 4.5 mm, or 5 mm (depending on the diameter of the self-expanding endoprosthesis 104) beyond the onset of plastic strain of the self-expanding stent element 100. The self-expanding stent element 100 of the self-expanding endoprosthesis 104 undergoes plastic strain after being deployed from the delivery configuration shown in FIG. 1C to the deployed configuration shown in FIG. 1B. showSelf-expanding endoprosthesis 104 can be delivered from a delivery (or collapsed) configuration to a deployed configuration for treatment at a target location within a patient's vasculature.
[0051] The as-manufactured diameter 102 of the self-expanding stent element 100 may be considered the diameter to which the self-expanding stent element 100 would deploy if no plastic strain had been induced and no graft component 106 had been coupled thereto. The expandable stent element 100 may be reduced from the as-manufactured diameter 102 of the self-expanding stent element 100 to couple a graft component 106 thereto. The as-manufactured diameter 102 of the self-expanding stent element 100 may be considered a neutral, nominal, self-expanding or unbiased diameter. For example, the neutral or nominal diameter 102 of the self-expanding stent element 100 may be the neutral or nominal diameter that the self-expanding stent element 100 would recover to if the self-expanding stent element 100 were not plastically deformed.
[0052] In certain cases, heat setting all or a portion of the self-expanding stent element 100 to a diameter larger than the expanded diameter 108 of the graft component 106 can pre-strain the self-expanding stent element 100. Pre-straining the self-expanding stent element 100 can counteract or offset the effects of the plastic deformation that occurs during the crushing / loading process that contracts the self-expanding endoprosthesis 104 from the deployed configuration shown in FIG. 1B to the delivery configuration shown in FIG. 1C.
[0053] The illustrative components shown in Figure 1 are not intended to suggest any limitations as to the scope of use or functionality of embodiments of the disclosed subject matter, nor should the illustrative components be construed as having any dependencies or requirements relating to any single component or combination of components shown therein. Moreover, any one or more of the components shown in any of Figures 1 may be combined in embodiments with various other components shown therein (and / or components not shown), all of which are contemplated to be within the scope of the disclosed subject matter.
[0054] FIG. 2A illustrates another exemplary self-expanding stent 200 at an as-manufactured diameter 202, consistent with various aspects of the present disclosure. The as-manufactured diameter 202 of the self-expanding stent 200 can be 2 mm to 13 mm, or 35 to 53 mm, or anything in between. In certain cases, the self-expanding stent 200 can be heat set at the as-manufactured diameter 202 of the self-expanding stent 200. Additionally, the self-expanding stent 200 can be a multi-apex wire-wound stent (e.g., as described in further detail with reference to FIG. 4). Additionally, the self-expanding stent 200 can form a portion of an implantable stent-graft device 204, as shown in FIG. 2B.
[0055] FIG. 2B illustrates a first configuration of the diametrical restraint 206 and the self-expanding stent element 200, with the diametrical restraint 206 at a first expanded diameter 208 and a second expanded diameter 210 as shown in FIG. 2A, consistent with various aspects of the present disclosure. As shown in FIG. 2B, the diametrical restraint 206 is a filament woven through a portion of the self-expanding stent element 200. The filament can be of a material similar to the continuous graft component. In other cases, the diametrical restraint 206 is a continuous graft component as opposed to a wire structure (e.g., as shown in FIG. 1B). In either case, the diametrical restraint 206 can be arranged such that the implantable stent graft device 204 includes multiple diameters. In certain cases, either the first expanded diameter 208 or the second expanded diameter 210 of the diametrical restraint 206 includes an expanded diameter between 5 mm and 27 mm. More specifically, the as-manufactured diameter 202 of the self-expanding stent 200 can be approximately 1 mm to 5 mm larger than either the first expanded diameter 208 or the second expanded diameter 210 of the diametrical constraint 206 .
[0056] In certain cases, the self-expanding stent element 200 can have a self-deployed diameter that is at least 2%-25% greater than the first expanded diameter 208 and the second expanded diameter 210 of the diametrical restraint 206 when the diametrical restraint 206 is attached. The self-deployed diameter of the self-expanding stent element 200 can be considered the diameter that the self-expanding stent element 200 would deploy to if the self-expanding stent element 200 were not coupled to the diametrical restraint 206. The self-expanding stent 200 is reduced from the as-manufactured diameter 202 of the self-expanding stent 200, thereby coupling the diametrical restraint 206 to the self-expanding stent 200. Additionally, and as described above, with reference to FIG. 1C, the implantable stent graft device 204 can be reduced to a delivery configuration for an implantation procedure into a patient. In certain cases, shrinking the implantable stent graft device 204 to a delivery configuration and / or shrinking the self-expanding stent element 200 from its manufactured diameter 202 can plastically deform the self-expanding stent element 200 such that the self-expanding stent element 200 can be configured to expand to a self-deployed diameter that is at least the first expanded diameter 208 and the second expanded diameter 210 of the diametrical constraint 206.
[0057] Additionally, the self-expanding stent elements 200 may be configured to continue to impose an outward force on the diametrical restraints 206 when the implantable stent graft device 204 is fully deployed (as shown in FIG. 2B ) without expanding beyond the first and second expanded diameters 208 and 210 of the diametrical restraints 206. Additionally, in certain cases, the diametrical restraints 206 may be configured to resist a radial expansion force greater than the outward force from the self-expanding stent elements 200 without expanding beyond the first and second expanded diameters 208 and 210. The radial expansion force may depend on the diameter of the self-expanding stent elements 200 and / or the diametrical restraints 206. For example, a larger diameter diametrical restraint 206 may be less resistant to an expansion force than a smaller diameter diametrical restraint 206. In certain cases, the radial expansion force is between 3 atmospheres and 6 atmospheres.
[0058] FIG 2C illustrates a second configuration of a diametrical restraint 206 attached to a self-expanding stent element 200 as shown in FIG 2A. As shown in FIG 2C, the diametrical restraint 206 is a wire structure woven through a portion of the self-expanding stent element 200. In other cases, the diametrical restraint 206 can be a continuous graft component as opposed to a wire structure (e.g., as shown in FIG 1B). The diametrical restraint 206 can be attached to the self-expanding stent element 200 such that the diametrical restraint 206 includes a single expanded diameter 212.
[0059] FIG. 3 illustrates an exemplary self-expanding endoprosthesis 300, 302 in a contracted configuration, consistent with various aspects of the present disclosure. Each of the self-expanding endoprostheses 300, 302 includes a graft component and a pre-strained stent component. The pre-strained stent component of the self-expanding endoprosthesis 300, 302 can include a reduced wire diameter to allow for the illustrated low-profile contracted (delivery) configuration. The wire diameter of the stent of the endoprosthesis can contribute to its structural strength. Forces can be applied when contracting the endoprosthesis to the contracted (delivery) configuration, and forces acting against the endoprosthesis when implanted in the body can limit the size of the wire diameter. Pre-straining the stent component of the self-expanding endoprosthesis 300, 302 can increase the ability of the stent component to withstand radial forces imposed on the self-expanding endoprosthesis 300, 302. Furthermore, the reduced wire diameter of the pre-strained stent component of the self-expanding endoprosthesis 300, 302 optimizes the reduced (delivery) configuration, allowing the self-expanding endoprosthesis 300, 302 to be reduced to a smaller reduced (delivery) configuration compared to a device of the same size without the pre-strained stent component when the wire diameter is equal.
[0060] As discussed in more detail below with reference to Figure 6, the prestrained stent component may also optimize the deployed diameter, radial force and fatigue life, and reduce stiffness due to the reduced wire diameter. Additionally, the prestrained stent component may also increase the crush resistance (radial) because it is in a prestrained state and / or because the prestrained stent component has an as-manufactured (or relaxed) stent diameter that is greater than the expanded diameter after attachment of the graft component.
[0061] 4 illustrates another exemplary implantable stent graft device 400, consistent with various aspects of the present disclosure. The self-expanding implantable stent graft device 400 includes a self-expanding stent element 402 and a graft component 404. As shown in FIG. 4, when the self-expanding stent element is not constrained by the graft component 404, the self-expanding stent element expands beyond the diameter of the graft component 404.
[0062] The self-expanding stent element 402 can have an as-manufactured diameter of 7 mm to 32 mm and the graft component 404 can have an expanded diameter of 5 mm to 27 mm. In certain cases, the self-expanding stent element 402 can have an as-manufactured diameter of 22 mm to 58 mm and the graft component 404 can have an expanded diameter of 20 mm to 53 mm, or 1 mm to 5 mm less than the as-manufactured diameter of the self-expanding stent element 402. More specifically, the as-manufactured diameter of the self-expanding stent element 402 can be approximately 1 mm to 3 mm greater than the expanded diameter of the graft component 404. Additionally, the self-expanding stent element 402 includes a self-deployed diameter that is 2% to 25% greater than the expanded diameter of the graft component 404 (e.g., when the self-expanding stent element 402 is not attached to the graft component 404). When the implantable stent graft device 400 is fully deployed, the self-expanding stent elements 402 may be configured to impose an outward force on the graft components 404 without expanding the graft components 404 beyond their expanded diameter. Additionally, in certain cases, the graft components 404 may be configured to resist a radial expansion force that is greater than the outward force from the self-expanding stent elements 402 without expanding beyond the expanded diameter of the graft components 404. The radial expansion force may depend on the diameter of the self-expanding stent elements 402 and / or the graft components 404. For example, a larger diameter graft component 404 will have less resistance to an expansion force than a smaller diameter graft component 404, such as a radial expansion force of 3 atmospheres to 6 atmospheres.
[0063] The self-expanding stent element 402 can include a plurality of undulations. As shown in Figure 4, the self-expanding stent element 402 includes a plurality of rows 406, 408, 410, 412 forming a plurality of undulations. Although two sets of undulations are highlighted, each of the plurality of undulations is formed by struts 414, 418 interconnected at apexes 416, 420. The apexes 416, 420 include arch ventral surfaces 422, 426 (inner portions of the apexes) and arch dorsal surfaces 424, 428 (outer portions of the apexes).
[0064] In certain cases, the graft component 404 can be attached to the self-expanding stent element 402 and configured to reduce tensile stresses at the arch ventral surfaces 422, 426 of the apexes 416, 420. In certain cases, reducing the implantable stent graft device 400 to a delivery configuration and / or reducing the self-expanding stent element 402 from an as-manufactured diameter to attach the graft component 404 to the self-expanding stent element 402 can plastically deform the self-expanding stent element 402 such that the arch ventral surfaces 422, 426 of the apexes 416, 420 are disposed in compression. After plastic deformation of the self-expanding stent element 402 and deployment of the self-expanding stent element 402 and graft component 404 to a fully deployed configuration, the tensile stresses at the arch ventral surfaces 422, 426 of the apexes 416, 420 are reduced because the expanded stent element 402 is maintained in a configuration smaller than the as-manufactured diameter. Arch abdominal surfaces 422, 426 that are under tension are more likely to break or fail than arch abdominal surfaces 422, 426 that are not under tension or compression. Thus, reducing the tension in the arch abdominal surfaces 422, 426 of the apex 416 can improve the fatigue resistance and reliability of the self-expanding stent element 402.
[0065] Additionally, the graft component 404 can be configured to attach to the self-expanding stent element 402 and maintain compression of the arch ventral surfaces 422, 426 of the apexes 416, 420. In certain cases, reduction in tensile stress can occur by maintaining the arch ventral surfaces 422, 426 of the apexes 416, 420 in compression. However, for illustrative purposes, the multiple undulating rows 410 of the self-expanding stent element 402 are shown unattached to the graft component 404. The compression of the attached arch ventral surface 426 compared to the unattached arch ventral surface 422 is illustrated by the difference in lengths 430, 432 between the struts 414, 418 as the length 432 between the struts 418 of the attached arch ventral surface 426 is less than the length 430 between the struts 414 of the unattached arch ventral surface 422 due to the attached arch ventral surface 426 being in compression.
[0066] In certain cases, the graft component 404 is configured to maintain compression of the arch ventral surfaces 422, 426 of the apexes 416, 420 in a fully deployed (expanded) configuration. Additionally, the graft component 404 is configured to maintain compression of the arch ventral surfaces 422, 426 in response to a radial expansion force greater than an outward force from the self-expanding stent element without expanding beyond an expanded diameter of the graft component 404. Additionally, the self-expanding stent element 402 can be reduced from a manufacturing diameter to couple the graft component 404 thereto. Additionally, and as described above with reference to FIGS. 1C and 3, the implantable stent graft device 400 can be reduced to a delivery configuration for implantation into a patient. As described above, reducing the implantable stent graft device 400 can plastically deform the self-expanding stent element 402 such that the arch ventral surfaces 422, 426 of the apexes 416, 420 are disposed in a compressed state.
[0067] The as-manufactured diameter of the self-expanding stent element 402 may be considered the neutral, nominal, self-deployed diameter or unbiased diameter. For example, the neutral or nominal diameter of the self-expanding stent element 402 may be the neutral or nominal diameter that the self-expanding stent element 402 would recover to if the self-expanding stent element 402 had not been plastically deformed.
[0068] Maintaining the arched ventral surfaces 422, 426 of the apexes 416, 420 in compression can reduce fracture of the self-expanding stent element 402. Tension at the arched ventral surfaces 422, 426 of the apexes 416, 420 can crack the arched ventral surfaces 422, 426, adversely affecting the fatigue life of the self-expanding stent element 402. Furthermore, maintaining the arched ventral surfaces 422, 426 of the apexes 416, 420 in compression can facilitate uniform expansion of the self-expanding device 400 from a delivery configuration to a fully deployed (expanded) configuration. Furthermore, crushing or reducing the self-expanding device 400 to a delivery configuration can plastically deform the self-expanding stent element 402 to ensure the ability of the graft component 404 to maintain the arched ventral surfaces 422, 426 of the apexes 416, 420 in compression.
[0069] 5 illustrates an exemplary self-expanding endoprosthesis 500 including a graft component 504 and a self-expanding stent element 502, with a portion 506 of the self-expanding stent element 502 detached from the graft component 504, consistent with various aspects of the present disclosure. For illustrative purposes, a portion of the self-expanding stent element 502 is shown detached from the graft component 504. All sides of the self-expanding stent element 502 can be attached to the graft component 504.
[0070] A portion of the self-expanding stent element 502 is shown removed from the graft component 504. The expandable stent element 502 can include a self-deployed diameter that is 2% to 25% larger than the expanded diameter of the graft component 504 (e.g., if the self-expanding stent element 502 were not attached to the graft component 504). The self-expanding stent element 502 can have an as-manufactured diameter of 5 mm to 27 mm (or 5 mm to 53 mm) and the graft element 504 can have an expanded diameter of 5 mm to 27 mm, or the self-expanding stent element 502 can have a diameter that is 1 mm to 5 mm (2% to 25%) larger than the graft component 504. In certain cases, the self-expanding stent element 502 can have an as-manufactured diameter of 22 mm to 58 mm and the graft element 504 can have an expanded diameter of 20 mm to 53 mm, or an expanded diameter that is 1 mm to 5 mm smaller than the as-manufactured diameter of the self-expanding stent element 502. More specifically, the as-manufactured diameter of the self-expanding stent element 502 can be larger than the expanded diameter of the graft component 504. Additionally, and in certain cases, the self-expanding stent element 502 can be oversized relative to the graft component 504 in the fully deployed configuration, thereby imposing an outward force on one of the graft components.
[0071] Additionally, the self-expanding stent element 502 can be contracted from its as-manufactured diameter to the expanded diameter of the graft component 504 for attachment to the graft component 504. By contracting the self-expanding stent element 502 or by contracting the self-expanding stent element 502 to a delivery configuration (e.g., as shown in FIGS. 1C and 3 ), the self-expanding stent element 502 expands to its self-deployed diameter but is held at the expanded diameter of the graft component 504 by attachment to the graft component 504.
[0072] When the implantable stent graft device 500 is fully deployed, the self-expanding stent elements 502 may be configured to exert an outward force on the graft component 504 without expanding the graft component 504 beyond its expanded diameter. Additionally, in certain cases, the graft component 504 may be configured to resist a radial expansion force greater than the outward force from the self-expanding stent elements 502 without expanding beyond the expanded diameter of the graft component 504 (e.g., the as-manufactured diameter of the graft component 504). The radial expansion force may depend on the diameter of the self-expanding stent elements 502 and / or the graft component 504. For example, a larger diameter graft component 504 may be less resistant to an expansion force than a smaller diameter graft component 504, where the radial expansion force is between 3 atmospheres and 6 atmospheres. For example, in certain cases, a radial expansion force of 3 atmospheres to 6 atmospheres for a period of 1, 2, 5, 10, 20, or 30 seconds without causing the diameter of the implantable stent graft device 500 to increase by more than approximately 0.5 mm.
[0073] The as-manufactured diameter of the self-expanding stent element 502 may be considered the neutral, nominal, self-deployed diameter or unbiased diameter. As described above, the self-expanding stent element 502 may be plastically deformed by reducing the self-expanding stent element 502 from its as-manufactured or nominal diameter. For example, the neutral or nominal diameter of the self-expanding stent element 502 may be the neutral or nominal diameter that the self-expanding stent element 502 would recover to if the self-expanding stent element 502 had not been plastically deformed.
[0074] The exemplary components shown in FIG. 5 are not intended to suggest any limitations as to the scope of use or functionality of the embodiments of the disclosed subject matter. Nor should the exemplary components be construed as having any dependencies or requirements relating to any single component or combination of components shown therein. Furthermore, any one or more of the components shown in FIG. 5 can be integrated in some embodiments with various other components depicted therein (and / or components not shown), all of which are considered to be within the scope of the disclosed subject matter. For example, the graft component 504 can be configured to maintain the apical arch ventral surfaces of the self-expanding stent elements 502 in compression, as described above with reference to FIG. 4.
[0075] FIG. 6 illustrates a graph consistent with various aspects of the disclosure. The graph includes plots 600, 602, and 604 of endoprostheses having graft and stent components, the stent components having various diameters. Plot 600 illustrates the radial force imposed on an endoprosthesis having a prestrained stent element with a wire diameter of 0.0185 inches at various endoprosthesis diameters. The prestrained stent has an as-manufactured diameter 4 mm greater than the expanded diameter of the graft component. Plot 602 illustrates the radial force imposed on an endoprosthesis having a prestrained stent element with a wire diameter of 0.0195 inches at various endoprosthesis diameters. The prestrained stent has an as-manufactured diameter 2 mm greater than the expanded diameter of the graft component. Plot 604 illustrates the radial force imposed on an endoprosthesis having a non-prestrained stent element with a wire diameter of 0.0205 inches at various endoprosthesis diameters.
[0076] The slope of plots 600, 602 (prestrained) is less than the slope of plot 604 (no prestrained). Prestraining the stent component can improve the ability of the stent component to withstand the radial forces imposed on the self-expanding endoprosthesis 300, 302. Thus, compared to the endoprosthesis of plot 604 (without prestrain and a larger wire diameter), the endoprosthesis of plots 600, 602 (prestrained) can be scaled to approximately the same or scaled down (delivery) configuration. In some cases, the endoprosthesis of plots 600, 602 (prestrained) can be scaled to a smaller delivery configuration.
[0077] Additionally, the endoprosthesis of plots 600, 602 (prestrained) can be approximately as resistant to radial compression at full deployment diameter as the endoprosthesis of plots 604 (no prestrained) while using a smaller diameter stent wire. Additionally, prestraining the stent frame can increase the material strain and resulting plastic deformation of the stent component 200 upon crushing / loading the endoprosthesis to its reduced (delivery) configuration. The plastic deformation can cause residual compressive stresses on the surfaces of the stent component (e.g., arch ventral surfaces 422, 426). Additionally, the stent component cannot expand beyond the graft diameter after deployment of the endoprosthesis, which can limit the amount of tensile load imparted to the compressively plastically deformed elements, thereby mitigating associated fatigue failure modes.
[0078] The example components shown in Figure 6 are not intended to suggest any limitations as to the scope of use or functionality of the embodiments of the disclosed subject matter, nor should the example components be construed as having any dependencies or requirements relating to any single component or combination of components shown therein. Furthermore, any one or more of the components shown in Figure 6 can be combined in some embodiments with various other components depicted therein (and / or components not shown), all of which are contemplated to be within the scope of the disclosed subject matter.
[0079] 7 illustrates a self-expanding endoprosthesis 700 consistent with various aspects of the present disclosure. Self-expanding endoprosthesis 700 can include a self-expanding stent element 702 and a graft component 704. Self-expanding endoprosthesis 700 can be tapered such that one end of self-expanding endoprosthesis 700 has a smaller diameter than the other end of self-expanding endoprosthesis 700, with a reduced diameter in the middle portion therebetween.
[0080] As discussed in further detail above, the self-expanding stent element 702 can be plastically deformed from an as-manufactured diameter (larger than the expanded diameter). The self-expanding stent element 702 can be configured to exhibit plastic deformation. The graft component 704 can be attached to the self-expanding stent element 702 such that the expanded diameter of the self-expanding stent element 702 (or the taper diameter of the self-expanding endoprosthesis 700) is 2% to 25% larger than the expanded diameter of the graft component 704 (or the taper diameter of the self-expanding endoprosthesis 700) after the self-expanding stent element 702 is plastically deformed from an as-manufactured diameter (larger than the expanded diameter).
[0081] The example components shown in Figure 7 are not intended to suggest any limitations as to the scope of use or functionality of the embodiments of the disclosed subject matter, nor should the example components be construed as having any dependencies or requirements relating to any single component or combination of components shown therein. Furthermore, any one or more of the components shown in Figure 7 can be combined in some embodiments with various other components depicted therein (and / or components not shown), all of which are contemplated to be within the scope of the disclosed subject matter.
[0082] 8 illustrates another self-expanding endoprosthesis consistent with various embodiments of the present disclosure. Self-expanding endoprosthesis 800 can include a self-expanding stent element 802 and a graft component 804. Self-expanding endoprosthesis 800 can include sections of different sizes such that the ends of self-expanding endoprosthesis 800 have a smaller diameter than the mid-section therebetween. Self-expanding endoprosthesis 800 can have a dog-bone shape as shown in FIG.
[0083] As discussed in more detail above, the self-expanding stent element 802 can be plastically deformed from an as-manufactured diameter (larger than the expanded diameter). In certain cases, only the ends of the self-expanding endoprosthesis 800 can be so configured. In other cases, the entire self-expanding endoprosthesis 800 can be configured such that the self-expanding stent element 802 is plastically deformed. The self-expanding stent element 802 can be configured to exhibit plastic deformation. The graft component 804 can be attached to the self-expanding stent element 802 such that the expanded diameter of the self-expanding stent element 802 (or the taper diameter of the self-expanding endoprosthesis 800) is 2% to 25% larger than the expanded diameter of the graft component 804 (or the taper diameter of the self-expanding endoprosthesis 800) after the self-expanding stent element 802 is plastically deformed from the as-manufactured diameter (larger than the expanded diameter).
[0084] The example components shown in Figure 8 are not intended to suggest any limitation as to the scope of use or functionality of the embodiments of the disclosed subject matter, nor should the example components be construed as having any dependency or requirement relating to any single component or combination of components shown therein. Furthermore, any one or more of the components shown in Figure 8 can be combined in some embodiments with various other components shown therein (and / or components not shown), all of which are contemplated to be within the scope of the disclosed subject matter.
[0085] As discussed herein, the graft components may be constructed from any material suitable for use as a graft in a selected body lumen and resistant to expansion beyond a desired dimension as discussed herein. The graft components may be constructed from the same or different materials. Furthermore, the graft components may include multiple layers of materials, which may be the same or different materials. Many graft materials are known, particularly those that can be used as vascular graft materials. In one embodiment, the materials may be used in combination and assembled together to comprise a graft. The graft materials used in the stent graft may be extruded, coated, or formed from packaging films, or may be combinations thereof. Polymers, biodegradable, and natural materials may be used for specific applications.
[0086] Examples of synthetic polymers, including but not limited to nylon, polyacrylamide, polycarbonate, polyformaldehyde, polymethylmethacrylate, polytetrafluoroethylene, polytrifluorochloroethylene, polyvinyl chloride, polyurethane, elastomeric organosilicon polymers, polyethylene, polypropylene, polyurethane, polyglycolic acid, polyester, polyamide, mixtures, blends and copolymers thereof, are suitable as graft materials. In one embodiment, the graft is made from polyesters such as polyethylene terephthalates, including DACRON® and MYLAR®, polyaramids such as KEVLAR®, polyfluorocarbons such as polytetrafluoroethylene with or without copolymerized hexafluoropropylene (such as TEFLON® or GORE-TEX®), and porous or non-porous polyurethanes. In certain cases, the graft comprises an expanded fluorocarbon polymer (particularly PTFE) material as described in British Patent Nos. 1,355,373, 1,506,432, 1,506,432, or U.S. Patent Nos. 3,953,566, 4,187,390, or 5,276,276, the entirety of which are incorporated by reference. Preferred classes of fluoropolymers include polytetrafluoroethylene (PTFE), fluorinated ethylene propylene (FEP), copolymers of tetrafluoroethylene (TFE) and perfluoro(propyl vinyl ether) (PFA), homopolymers of polychlorotrifluoroethylene (PCTFE) and its copolymers with TFE, ethylene-chlorotrifluoroethylene (ECTFE), copolymers of ethylene-tetrafluoroethylene (ETFE), polyvinylidene fluoride (PVDF) and polyvinyl fluoride (PVF). Particularly preferred is ePTFE due to its widespread use in vascular prostheses. In certain cases, the graft comprises a combination of the materials listed above. In certain cases, the graft is substantially impermeable to body fluids.The substantially impermeable graft can be made from materials that are substantially impermeable to bodily fluids, or can be constructed from permeable materials that have been treated or manufactured to be substantially impermeable to bodily fluids (e.g., by layering different types of materials as described above or known in the art).
[0087] Additional examples of graft materials include, but are not limited to, vinylidene fluoride / hexafluoropropylene hexafluoropropylene (HFP), tetrafluoroethylene (TFE), vinylidene fluoride, 1-hydropentafluoropropylene, perfluoro(methyl vinyl ether), chlorotrifluoroethylene (CTFE), pentafluoropropene, trifluoroethylene, hexafluoroacetone, hexafluoroisobutylene, fluorinated poly(ethylene-co-propylene) (FPEP), poly(hexafluoropropene) (PHFP). , poly(chlorotrifluoroethylene) (PCTFE), poly(vinylidene fluoride) (PVDF), poly(vinylidene fluoride-co-tetrafluoroethylene) (PVDF-TFE), poly(vinylidene fluoride-co-hexafluoropropene) (PVDF-HFP), poly(tetrafluoroethylene-co-hexafluoropropene) (PTFE-HFP), poly(tetrafluoroethylene-co-vinyl alcohol) (PTFE-VAL), poly(tetrafluoroethylene-co-vinyl acetate (PTFE-VAC), poly(tetrafluoroethylene-co-pro Poly(vinylidene fluoride-co-chlorotrifluoroethylene) (PVDF-CTFE) and combinations thereof, and additional polymers and copolymers described in U.S. Patent Application Publication No. 2004 / 0063805, which is incorporated herein by reference in its entirety for all purposes. Additional polyfluoro copolymers include tetrafluoroethylene (TFE) / perfluoroalkyl vinyl ether (PAVE). PAVE can be perfluoromethyl vinyl ether (PMVE), perfluoroethyl vinyl ether (PEVE) or perfluoropropyl vinyl ether (PPVE), as described essentially in U.S. Patent Application Publication No. 2006 / 0198866 and U.S. Patent No. 7,049,380, both of which are incorporated herein by reference in their entirety for all purposes.Other polymers and copolymers include polylactides, polycaprolactone-glycolides, polyorthoesters, polyanhydrides, polyamino acids, polysaccharides, polyphosphazenes, poly(ether-ester) copolymers such as PEO-PLLA or blends thereof, polydimethyl-siloxanes, poly(ethylene-vinyl acetate), acrylate-based polymers or copolymers such as poly(hydroxyethylmethylmethacrylate), polyvinylpyrrolidinone, fluorinated polymers such as polytetrafluoroethylene, cellulose esters; and any of the polymers and copolymers described in U.S. Patent Publication No. 2004 / 0063805, which is incorporated herein by reference in its entirety.
[0088] The graft components discussed herein can be attached to the self-expanding stent components by using a connecting member that is a generally flat ribbon or tape having at least one generally flat surface. In certain cases, the tape member is made of expanded PTFE (ePTFE) coated with an adhesive. The adhesive can be a thermoplastic adhesive. In certain cases, the thermoplastic adhesive can be fluorinated ethylene propylene (FEP). More specifically, the FEP-coated surface of the ePTFE can face and contact the outer surfaces of the self-expanding stent and the graft components, thus attaching the self-expanding stent to the graft components. Materials and methods for attaching stents to grafts are discussed in U.S. Patent No. 6,042,602 to Martin, which is incorporated herein by reference for all purposes.
[0089] The stent elements discussed herein can be manufactured from a variety of biocompatible materials. These materials can include 316L stainless steel, cobalt-chromium-nickel-molybdenum-iron alloy ("cobalt-chromium"), other cobalt alloys such as L605, tantalum, nitinol, or other biocompatible metals. In certain cases, as discussed in detail above, the stent (and graft) can be self-expanding. The prosthesis can be balloon-expandable.
[0090] Wire-wound stents can be constructed from reasonably high strength materials, i.e., materials that are resistant to plastic deformation when subjected to stress. In certain cases, the stent includes a wire helically wound around a mandrel with pins positioned to simultaneously form the helical turns and undulations, as described below. Other constructions can also be used. For example, the appropriate shape can be formed from flat stock and rolled into a cylinder, or formed from laser cutting a length of tubing or sheet of material that has been processed into the appropriate shape. In certain cases, the stent is made from a superelastic alloy. There are various disclosures in which superelastic alloys, such as Nitinol, are used in stents. See, for example, U.S. Pat. Nos. 4,503,569 to Dotter, 4,512,338 to Balko et al., 4,990,155 to Wilkoff, 5,037,427 to Harada et al., 5,147,370 to MacNamara, 5,211,658 to Clouse, and 5,221,261 to Termin et al.
[0091] Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the above-described embodiments refer to particular features, the scope of the present invention also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of the present invention is intended to include all alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof. (Aspect) (Aspect 1) 1. A self-expanding endoprosthesis having a collapsed configuration and an expanded configuration, the self-expanding endoprosthesis comprising: a self-expanding stent element having an enlarged diameter; a graft component attached to at least a portion of the self-expanding stent element and having an expanded diameter less than an expanded diameter of the self-expanding stent element in the deployed configuration; wherein in the deployed configuration, the self-expanding stent elements exert a radial expansion force on the graft component, the graft component having a yield strength greater than the radial expansion force and configured to radially maintain the self-expanding stent elements at the expanded diameter of the graft component upon application of a second radial expansion force greater than the radial expansion force of the self-expanding stent elements. (Aspect 2) 2. The self-expanding endoprosthesis of embodiment 1, wherein the graft component is configured to resist plastic deformation upon application of the second radial expansion force. (Aspect 3) 3. The self-expanding endoprosthesis of any one of the preceding claims, wherein the expanded diameter of the self-expanding stent element is 2% to 25% greater than the expanded diameter of the graft component. (Aspect 4) 4. The self-expanding endoprosthesis of any one of embodiments 1-3, wherein the graft component is a continuous structure attached to the self-expanding stent element and forms a flow lumen of the self-expanding endoprosthesis. (Aspect 5) 5. The self-expanding endoprosthesis of any one of the preceding embodiments, wherein the self-expanding stent element includes a plurality of undulations formed by struts connecting apices. (Aspect 6) 6. The self-expanding endoprosthesis of embodiment 5, wherein the apex includes an arch ventral surface and an arch posterior surface, and the graft component is configured to reduce tensile stress at the arch ventral surface of the apex. (Aspect 7) 6. The self-expanding endoprosthesis of embodiment 5, wherein the apex includes an arch ventral surface and an arch posterior surface, and the graft component is configured to maintain compression of the apex arch ventral surface. (Aspect 8) 8. The self-expanding endoprosthesis of embodiment 7, wherein the self-expanding stent element and graft component are contracted to a contracted configuration and the apex arch ventral surfaces remain compressed after expansion to a deployed configuration. (Aspect 9) The self-expanding endoprosthesis of any one of the preceding embodiments, wherein the self-expanding stent elements are heat-set to an as-manufactured diameter. (Aspect 10) 10. The self-expanding endoprosthesis of embodiment 9, wherein the as-manufactured diameter of the self-expanding stent element is 15% to 20% larger than the expanded diameter of the graft component. (Aspect 11) 11. The self-expanding endoprosthesis of any one of embodiments 1-10, wherein the as-manufactured diameter of the self-expanding stent element is about 1 mm to 3 mm larger than the expanded diameter of the graft component. (Aspect 12) The self-expanding stent and graft components of any one of the embodiments 1 to 11 are configured to be compressed to a reduced diameter of between 4 French and 26 French. endoprosthesis. (Aspect 13) 13. The self-expanding endoprosthesis of embodiment 12, wherein the expanded diameter of the graft component is between 2 mm and 53 mm. (Aspect 14) 14. The self-expanding endoprosthesis of any one of the preceding embodiments, wherein the self-expanding stent element has an as-manufactured diameter of 7 mm to 32 mm, and the graft component has an expanded diameter of 5 mm to 27 mm. (Aspect 15) 15. The self-expanding endoprosthesis of embodiment 14, wherein the graft component is configured to resist a radial expansion force greater than an outward force from the self-expanding stent component without expanding beyond an expanded diameter of the graft component, and the radial expansion force is between 3 atmospheres and 6 atmospheres.
Claims
1. 1. A self-expanding endoprosthesis having a collapsed configuration and an expanded configuration, the self-expanding endoprosthesis comprising: a self-expanding stent element having an expanded diameter and including an apex including an arch ventral surface and an arch dorsal surface, the self-expanding stent element being configured to exhibit plastic strain at the expanded diameter in the deployed configuration and in response to contracting to the contracted configuration; a graft component attached to at least a portion of the self-expanding stent element and having an expanded diameter less than the expanded diameter of the self-expanding stent element in the deployed configuration; wherein in the deployed configuration, the self-expanding stent elements exert a radial expansion force on the graft component, the graft component having a yield strength greater than the radial expansion force and configured to radially maintain the self-expanding stent elements at the expanded diameter of the graft component upon application of a second radial expansion force greater than the radial expansion force of the self-expanding stent elements, the graft component configured to maintain compression of the arch ventral surfaces of the apexes.
2. The self-expanding endoprosthesis of claim 1 , wherein the graft component is configured to resist plastic deformation upon application of the second radial expansion force.
3. The self-expanding endoprosthesis of claim 1 , wherein the expanded diameter of the self-expanding stent element is between 2% and 25% greater than the expanded diameter of the graft component.
4. The self-expanding endoprosthesis of any one of claims 1 to 3, wherein the graft component is a continuous structure attached to the self-expanding stent element and defines a flow lumen of the self-expanding endoprosthesis.
5. The self-expanding endoprosthesis of claim 1 , wherein the self-expanding stent element includes a plurality of undulations formed by struts connecting the apices.
6. The self-expanding endoprosthesis of claim 5 , wherein the graft component is configured to reduce tensile stresses at the apical ventral arch surfaces.
7. 10. The self-expanding endoprosthesis of claim 1, wherein the self-expanding stent and graft components are contracted to a collapsed configuration and the apex arch ventral surfaces remain compressed after expansion to a deployed configuration.
8. The self-expanding endoprosthesis of any one of claims 1 to 7, wherein the self-expanding stent element is heat set to an as-manufactured diameter.
9. The self-expanding endoprosthesis of claim 8 , wherein the as-manufactured diameter of the self-expanding stent element is between 15% and 20% larger than the expanded diameter of the graft component.
10. The self-expanding endoprosthesis of any one of claims 1 to 9, wherein the as-manufactured diameter of the self-expanding stent element is between 1 mm and 3 mm larger than the expanded diameter of the graft component.
11. The self-expanding endoprosthesis of any one of claims 1 to 10, wherein the self-expanding stent and graft components are configured to compress to a reduced diameter of between 4 French and 26 French.
12. The self-expanding endoprosthesis of claim 11 , wherein the expanded diameter of the graft component is between 2 mm and 53 mm.
13. The self-expanding endoprosthesis of any one of claims 1 to 12, wherein the self-expanding stent element has an as-manufactured diameter of 7 mm to 32 mm and the graft component has an expanded diameter of 5 mm to 27 mm.
14. 14. The self-expanding endoprosthesis of claim 13, wherein the graft component is configured to resist a radial expansion force greater than an outward force from the self-expanding stent element without expanding beyond the expanded diameter of the graft component, and the radial expansion force is between 3 atmospheres and 6 atmospheres.
15. 1. A self-expanding endoprosthesis having a collapsed configuration and an expanded configuration, the self-expanding endoprosthesis comprising: a self-expanding stent element having an expanded diameter and including an apex including an arch ventral surface and an arch dorsal surface, the self-expanding stent element being configured to exhibit plastic strain at the expanded diameter in the deployed configuration and in response to contracting to the contracted configuration; a graft component having an expanded diameter smaller than the expanded diameter of the self-expanding stent element in the deployed configuration; wherein in the deployed configuration, the self-expanding stent elements exert a radial expansion force on the graft component, the graft component having a yield strength greater than the radial expansion force and configured to radially maintain the self-expanding stent elements at the expanded diameter of the graft component upon application of a second radial expansion force greater than the radial expansion force of the self-expanding stent elements, the self-expanding stent elements being heat set to an as-manufactured diameter, the as-manufactured diameter of the self-expanding stent elements being 15% to 20% greater than the expanded diameter of the graft component, and the graft component configured to maintain compression of the arch ventral surfaces of the apexes.
Citation Information
Patent Citations
Kink-resistant stent-graft
JP1999509130A
Multi-stage expandable stent / graft
JP2002531219A
intraluminal stent graft
JP2003505144A
Biodegradable, antibiotic, controlled release tape
US20050129732A1
Sleeve for medical device assembly
US20140120287A1
